comparemela.com

Latest Breaking News On - Serum life science - Page 1 : comparemela.com

Adar Poonawalla | Vaccine prince Adar Poonawalla splurges on a trophy London home outspending Mukesh Ambani and other Indian billionaires

View: Eminent rise of M&As

Despite the global challenges of high interest rates and geopolitical uncertainties, the economy remains resilient, buoyed by rising domestic demand and sectoral recovery. The outlook for H2 FY2023 and FY2024 looks positive, suggesting a resurgence in deals as market valuations stabilise. The financial health of the Indian companies is underscored by data from S&P Global Ratings, which projects a remarkable 50% increase in EBITDA by FY2024, while debt levels remain stable. This reflects a positive outlook for the corporate sector, demonstrating the strength of India s economy in the face of global adversity.

Serum Life Sciences to make additional $150 million funding in Biocon Biologics

This investment is in addition to the $ 150 million that SILS had invested in Biocon Biologics in November 2022, resulting in SILS’s aggregate equity investment in BBL amounting to $300 million.

With $68 2M investment from India s Serum, Oxford Biomedica set to add capacity and 120 jobs at its Oxbox site

With $68 2M investment from India s Serum, Oxford Biomedica set to add capacity and 120 jobs at its Oxbox site
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.